Cancer Center Profile

Offering medical, surgical, and radiation oncology, the Hallmark Health Hematology and Oncology Center provides local access to personalized, comprehensive, high-quality cancer care. Located in Stoneham, Massachusetts, about 7 miles north of Boston, the center is part of Hallmark Health System, which also includes 2 community hospitals, Lawrence Memorial Hospital of Medford and Melrose-Wakefield Hospital.

After the Great Chicago Fire in 1871, Chicago became one of the fastest growing cities in the world. But in this time of prosperity and growth, the prognosis for children born in the city was grim. A child had only a 50% chance of surviving to the age of 5 years, and those who survived were likely to be exposed to a host of diseases. In 1882, Julia Foster Porter took bold steps to transform the future of children’s health in Chicago by renovating a modest home and establishing Chicago’s first—and still its only—hospital dedicated exclusively to caring for children.

Clinical oncology pharmacists evaluate and treat pain through pain management consultations at Porter Cancer Care Center. As part of the comprehensive cancer treatment program at Porter Adventist Hospital in Denver, Colorado, Robin Mower, PharmD, and colleagues provide one-on-one pain evaluation consults to enhance the quality of life of patients with cancer. Fortunately, Colorado allows collaborative drug therapy management (CDTM) between physicians and pharmacists, allowing the clinical pharmacists at Porter Adventist Hospital to provide pain management under the CDTM protocol.

This past April, Mountain States Health Alliance’s Regional Cancer Center celebrated the 1-year anniversary of its new, state-of-theart oncology pharmacy. Located in the Regional Cancer Center’s dedicated medical oncology facility, the pharmacy provides USP <797>-compliant chemotherapy and supportive care agents as well as the benefit of face-to-face collaboration between pharmacists and the rest of the cancer care team.

After a diagnosis of cancer, patients often initiate or increase their use of vitamins and dietary supplements, and their use is prevalent among the 11.7 million adults in the United States living with cancer. Whereas 50% of healthy adults take 1 or more dietary supplements, between 64% and 81% of cancer survivors report that they use vitamin or dietary supplements.1 Reasons offered for using these alternative therapies include strengthening the immune system, increasing the chance to be cured, and gaining a sense of control over their disease.

Following a lung cancer diagnosis, patients typically embark on a dizzying journey that takes them from one waiting room to another, as they follow their treatment plan from the medical oncologist to the surgical oncologist to the radiation oncologist and back again. Coordinating these visits imposes yet another burden on the patient and often leads to delays in care. Six years ago, St. Joseph Mercy Cancer Center in Ypsilanti, Michigan, decided to simplify life for their patients by opening a multidisciplinary lung cancer clinic.

A phase III trial investigating ruxolitinib found the oral drug effective at reducing spleen swelling in patients with myelofibrosis, a rare hematologic cancer. Ruxolitinib is an inhibitor of Janus kinases (JAKs) 1 and 2 and interleukin (IL)-6 signaling. Incyte Corporation and Novartis are collaborating on development of ruxolitinib and have announced plans to apply for regulatory approval in the United States and Europe within the next few months based on data from this and another pivotal phase III trial.

What started as tumor board conferences a decade ago has grown into a true multidisciplinary team approach to comprehensive breast care. ProHealth Care’s Center for Breast Care at Waukesha Memorial Hospital’s Regional Cancer Center in Waukesha, Wisconsin, is an interdisciplinary breast cancer clinic where patients can see multiple specialists in one visit. With the opening of the clinic, the various specialists involved in patient care can talk to each other about a patient in real time, not replacing tumor board conferences, but taking patient care to the next level.

Page 3 of 3
Results 21 - 28 of 28